Mickey082024

Value investor and Long Terms

    • Mickey082024Mickey082024
      ·08-25

      QQQ Falls 1%: Warsh and Bessent Clash at Jackson Hole — Who Sets the Tone?

      $Invesco QQQ(QQQ)$ The Nasdaq-100 ETF (NASDAQ: QQQ) fell approximately 1% as investors reacted to a sharp policy debate emerging from Jackson Hole. At the center of the discussion were Kevin Warsh, a former Federal Reserve governor, and Treasury Secretary Scott Bessent. Their disagreement reflects a broader market question: Should investors focus on the Federal Reserve’s inflation-fighting credibility, or on the possibility that fiscal policy, tariffs and economic growth are creating room for lower interest rates? The answer matters because QQQ is heavily weighted toward long-duration technology companies. When bond yields rise, the present value of future earnings falls, putting pressure on high-growth stocks even when their operating results rema
      400Comment
      Report
      QQQ Falls 1%: Warsh and Bessent Clash at Jackson Hole — Who Sets the Tone?
    • Mickey082024Mickey082024
      ·08-25

      Alibaba Slips 0.73% as Burry Bears Down — CEO Buys $4.98 Million: Who’s Wrong?

      $Alibaba(BABA)$ Alibaba Group Holding Ltd. (NYSE: BABA) has suddenly become a battleground between two very different investment philosophies. On one side is Michael Burry, the investor made famous by The Big Short, who has exited Alibaba and shifted his capital toward rival JD.com. Burry argues that Alibaba’s decision to issue roughly $10.2 billion of new shares to finance artificial-intelligence investment signals potentially poor returns on invested capital. He has reportedly said Alibaba would need to fall roughly 50% before he becomes interested again. On the other side is Alibaba's own management. CEO Eddie Wu purchased 350,000 Alibaba shares for approximately $4.984 million, at an average price of $14.24 per share on the Form 4 reporting ba
      5912
      Report
      Alibaba Slips 0.73% as Burry Bears Down — CEO Buys $4.98 Million: Who’s Wrong?
    • Mickey082024Mickey082024
      ·08-23

      Nike Stock: Is the Swoosh Finally Cheap Enough to Buy?

      $Nike(NKE)$ Nike (NYSE: NKE) has fallen to roughly $41, a level not seen in more than a decade. The stock looks cheap on the surface, but the deeper question is whether investors are buying a damaged brand or a temporarily impaired franchise. Nike's latest fiscal results show a company still struggling with weak demand, China, product freshness and profitability. Fiscal 2026 revenue was $46.4 billion, essentially flat year over year and down 2% on a currency-neutral basis. Net income declined 3% to $3.1 billion, while diluted EPS fell to $2.10. At the same time, there are reasons not to write Nike off. North America has shown resilience, wholesale is recovering, management is rebuilding its product pipeline, and the company still owns one of the wo
      1.36K3
      Report
      Nike Stock: Is the Swoosh Finally Cheap Enough to Buy?
    • Mickey082024Mickey082024
      ·06-30

      The Valuation Disconnect: Why Concentrix Corp’s Steep Correction Presents a Generational Value Opportunity for Patient Capital

      $Concentrix Corp(CNXC)$ The global customer experience (CX) and business process outsourcing (BPO) industry is undergoing a structural transition. As enterprise buyers balance the integration of automated generative artificial intelligence solutions with human-centric support architectures, corporate equity valuations have decoupled from near-term execution. No company embodies this transition—and the resulting market volatility—more visibly than Concentrix Corporation (NASDAQ: CNXC). Following its second-quarter fiscal 2026 earnings release, Concentrix witnessed a dramatic 25% single-day liquidation, sending its stock price hovering near the $19.80 mark. This sell-off reflects a wider narrative shift across Wall Street regarding the long-term imp
      4.43K1
      Report
      The Valuation Disconnect: Why Concentrix Corp’s Steep Correction Presents a Generational Value Opportunity for Patient Capital
    • Mickey082024Mickey082024
      ·06-24

      Navigating the Weibo Valuation Dichotomy: Trap or Generational Value?

      $Weibo(WB)$ $WB-SW(09898)$ In the hyper-evolving landscape of Chinese digital media, few platforms occupy as unique or as paradoxically contested a position as Weibo Corporation (NASDAQ: WB; HKEX: 9898). Long heralded as China’s public town square—a critical hybrid of social network and real-time informational broadcast engine—the company currently finds itself at a profound financial crossroad. Equity markets have fundamentally reset the company’s valuation multi-year baselines, compressing multiples to levels typically reserved for businesses facing terminal structural decline. Yet, beneath the visible technical damage on the price charts lies a highly profitable enterprise executing a complex strategic
      1.95KComment
      Report
      Navigating the Weibo Valuation Dichotomy: Trap or Generational Value?
    • Mickey082024Mickey082024
      ·06-16

      FIS Stock Research: Deep Value Play or Value Trap?

      $Fidelity National Information(FIS)$ Fidelity National Information Services (NYSE: FIS) is experiencing a dramatic divergence between its underlying corporate execution and its stock price performance. While the financial technology (fintech) giant is hitting its operational strides and beating quarterly earnings expectations, the stock has collapsed into deep value territory. This research uncovers the underlying drivers of the business, analyzes its balance sheet risks, and evaluates whether the recent market sell-off presents a compelling buying opportunity. Performance Overview and Market Feedback The market sentiment surrounding FIS has turned aggressively bearish over the last year. The stock recently plunged to a 52-week low of $38.78, repre
      2.18KComment
      Report
      FIS Stock Research: Deep Value Play or Value Trap?
    • Mickey082024Mickey082024
      ·06-14

      Zoetis At A Crossroads: Is The Animal Health Leader A Buy After Its 2026 Valuation Reset?

      $Zoetis(ZTS)$ The animal health sector long enjoyed an aura of absolute invulnerability, and Zoetis (NYSE: ZTS) was its undisputed crown jewel. However, a major shift in consumer behavior and sharpening generic and brand competition have shattered that narrative. Following a bruising first-quarter earnings report, Zoetis stock experienced a severe single-day collapse of nearly 21%. Now trading in the low-$80s—down more than 50% from its rolling one-year highs—the market is aggressively pricing in structurally slower growth. For long-term investors, the central question is whether this sell-off is a permanent impairment or an exceptional entry point for a world-class monopoly. Performance Overview and Market Feedback The market's feedback on Zoetis
      2.21KComment
      Report
      Zoetis At A Crossroads: Is The Animal Health Leader A Buy After Its 2026 Valuation Reset?
    • Mickey082024Mickey082024
      ·06-04

      Copart, Inc. (CPRT): Analyzing the Deep Sell-Off and Seeking the Ultimate Entry Value

      $Copart(CPRT)$ Performance Overview and Market Feedback Online auto-auction giant Copart, Inc. (CPRT) has recently found itself in unfamiliar territory. Long regarded as an untouchable, high-moat compounder, the stock has experienced a brutal downward cycle over the past year. Shares have tumbled approximately 21% year-to-date and nearly 40% over the last 52 weeks, hovering painfully close to a 52-week low of roughly $30.86 to $32.20. This deep underperformance stands in sharp contrast to a resilient S&P 500 trading near all-time highs. Wall Street's feedback has shifted from unbridled optimism to cautious hesitation. While boutique growth bulls argue that the underlying business remains inherently healthy, major institutions like Barclays and
      2.87KComment
      Report
      Copart, Inc. (CPRT): Analyzing the Deep Sell-Off and Seeking the Ultimate Entry Value
    • Mickey082024Mickey082024
      ·03-13

      Gold and Silver Retreat: Can Safe-Haven Demand Outpace the Surging Dollar?

      $SPDR Gold ETF(GLD)$ $iShares Silver Trust(SLV)$ Gold and silver markets are currently caught in one of the most classic macroeconomic tug-of-wars in commodities: safe-haven demand versus a strengthening U.S. dollar. On one side, geopolitical tensions, inflation concerns, and economic uncertainty are pushing investors toward precious metals as defensive assets. On the other, the U.S. dollar — itself a global safe haven — has surged, creating powerful headwinds for bullion prices. The result is a volatile and confusing market environment where gold and silver often rally intraday on risk fears but retreat as currency markets reassert themselves. Understanding this dynamic is essential for investors trying to
      4.01KComment
      Report
      Gold and Silver Retreat: Can Safe-Haven Demand Outpace the Surging Dollar?
    • Mickey082024Mickey082024
      ·03-13

      Diageo Stock: A Premium Spirits Giant Faces Market Hangover — Is This a Rare Buying Opportunity?

      $Diageo PLC(DEO)$ Few consumer brands possess the global scale, pricing power, and heritage of Diageo. The company sits at the center of the premium spirits industry, owning some of the most recognizable beverage brands in the world, including Johnnie Walker, Guinness, Smirnoff, Don Julio, and Tanqueray. For decades, Diageo has been considered one of the most resilient consumer staples companies in the global market. Its portfolio of premium spirits, international distribution reach, and ability to raise prices have historically allowed the company to deliver steady revenue growth, strong free cash flow, and dependable dividends. Yet despite this reputation, the company’s American Depositary Shares — traded in the U.S. under the ticker DEO — have e
      4.65K2
      Report
      Diageo Stock: A Premium Spirits Giant Faces Market Hangover — Is This a Rare Buying Opportunity?
       
       
       
       

      Most Discussed